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Abstract
Introduction 
The National Health and Nutrition Examination Survey (NHANES) included accelerometry in the 2003–2006 data 
collection cycles. Researchers have used these data since their release in 2007, but the data have not been consistently 
treated, examined, or reported. The objective of this study was to aggregate data from studies using NHANES 
accelerometry data and to catalogue study decision rules, derived variables, and cut point definitions to facilitate a 
more uniform approach to these data.
Methods 
We conducted a PubMed search of English-language articles published (or indicated as forthcoming) from January 
2007 through December 2011. Our initial search yielded 74 articles, plus 1 article that was not indexed in PubMed. 
After excluding 21 articles, we extracted and tabulated details on 54 studies to permit comparison among studies.
Results 
The 54 articles represented various descriptive, methodological, and inferential analyses. Although some decision rules 
for treating data (eg, criteria for minimal wear-time) were consistently applied, cut point definitions used for 
accelerometer-derived variables (eg, time spent in various intensities of physical activity) were especially diverse.
Conclusion 
Unique research questions may require equally unique analytical approaches; some inconsistency in approaches must 
be tolerated if scientific discovery is to be encouraged. This catalog provides a starting point for researchers to consider 
relevant and/or comparable accelerometer decision rules, derived variables, and cut point definitions for their own 
research questions.
Introduction
The National Health and Nutrition Examination Survey (NHANES) is a publicly available data resource that provides 
information from self- or proxy reports of health conditions and behaviors and biomedical data for a sample 
representing the US civilian noninstitutionalized population (www.cdc.gov/nchs/nhanes.htm). NHANES is 
administered in 2-year data collection cycles; the Physical Activity Monitor (PAM) component was introduced in the 
2003–2004 and 2005–2006 cycles to collect accelerometer-based measures of physical activity among participants 
aged 6 years or older. During these 2 cycles, an ActiGraph model 7164 accelerometer (ActiGraph, LLC, Pensacola, 
Florida) was provided to ambulatory participants, representing the first time that a surveillance study collected 
accelerometer measures on a US representative sample.
The uniaxial accelerometer measured and recorded vertical acceleration as “activity counts.” The device also recorded 
“steps” by using a proprietary signal-filtering algorithm. These 2 related quantities measure physical activity 
movement associated primarily with locomotion. A 1-minute time interval, or “epoch,” was used in NHANES. Data for 
activity counts and steps were recorded during each epoch for up to 1 week. Both activity count and step data were 
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released for the 2005–2006 NHANES cycle, but because of missing step data on a portion of the sample in the 2003–
2004 cycle, only activity count data were released for that cycle. The data are available from 
http://www.cdc.gov/nchs/nhanes.htm; the National Cancer Institute (NCI) offers SAS (SAS Institute, Inc, Cary, North 
Carolina) syntax for analyzing the data at http://riskfactor.cancer.gov/tools/nhanes_pam/. The syntax facilitates the 
editing of invalid and unreliable intensity values (defined by NCI) and summarizes derived variables that describe the 
duration of nonwear periods and activity bouts of moderate, vigorous, and moderate-to-vigorous intensities. The NCI 
website acknowledges that “users can modify these programs to examine other issues, such as alternate definitions of 
valid data, monitor wear periods, or activity bouts.”
The release of PAM data in 2007 provided researchers a unique opportunity to study objectively measured physical 
activity on a large and representative US sample and relate it to a range of other health-related variables. Numerous 
studies using the data have been published, but these studies have treated, analyzed, and reported the data by using 
myriad accelerometer decision rules, derived variables, and cut point definitions. A catalog of these rules, variables, 
and definitions is needed so that researchers can begin to work toward more standardized and comparable data. The 
objective of this study was to catalogue the accelerometer decision rules, derived variables, and cut point definitions 
used in studies on PAM data published since 2007.
Methods
Data sources
We conducted an advanced English-only literature search of original research articles in PubMed by using the key 
terms “activity monitor” or “ActiGraph” or the wildcard term “acceleromet*” in addition to “NHANES” or “National 
Health and Nutrition Examination Survey.” We searched articles published from January 1, 2007, through December 
31, 2011. We used the following search strategy: (“activity monitor” OR ActiGraph OR acceleromet*) AND (NHANES 
OR “National Health and Nutrition Examination Survey”) AND English[Language] AND (“2007/01/01”[Date of 
publication]: “2011/12/31”[Date of publication]). We included forthcoming and “epub ahead of print” articles and 
updated the search on February 10, 2012. We found 74 articles that met our search criteria. One author (R.P.T.) 
identified 1 other published study, prepared for a special conference, not indexed in PubMed (1) bringing the initial 
search total to 75 articles.
Study selection
Twenty-one articles (28%) did not directly analyze PAM data, and they were eliminated; the remaining 54 articles 
(72%) were included in this review.
Data extraction
The first author read and abstracted the following details from each identified article: 1) citation; 2) purpose of study; 
3) PAM data collection cycle(s) analyzed (ie, 2003–2004 and/or 2005–2006); 4) study sample size and age of 
participants in sample; 5) whether investigators reported using the NCI-supplied SAS syntax; 6) rules for defining 
nonwear time (ie, time that the accelerometer was not likely worn), a valid day (ie, the minimum number of wear-
hours required to be considered representative of a day’s behavior), and the minimum number of valid days required 
for a participant to be included in the analysis; 7) accelerometer-derived variables (eg, activity counts/day, time spent 
in moderate-intensity activity, steps in vigorous-intensity activity); and 8) cut point definitions used for each 
accelerometer-derived variable (ie, values used to categorize continuous data). The second author verified the details 
independently. Discrepancies were discussed and consensus achieved. The results were tabulated to facilitate 
comparison among studies. We made no attempt to contact the articles’ authors to obtain unreported information or 
clarify writing; data extraction was made on face value.
Results
The purpose of the 54 articles varied (Table 1); they represented, for example, descriptive analyses (2-5), 
methodological analyses (1,6,7), and inferential analyses (8-10). Eighteen studies used the NHANES 2003–2004 cycle, 
15 used the 2005–2006 cycle, and 21 combined data from both cycles. Sample sizes ranged from 103, representing 
prostate cancer survivors (11), to 6,329, representing participants with 1 or more days of wear in the 2003–2004 cycle 
(2,3). Fourteen studies focused primarily on children and/or adolescents (through age 19 y), 33 on adults (including 1 
study on all participants aged ≥16 y), 2 on older adults, and 3 on all ages (ie, ≥6 y). Two reported only the mean age of 
cancer survivors.
Twenty-four studies reported using the NCI-supplied SAS syntax (1,2,4,5,7,9,10,12-28). Eight studies (11,29-35) cited 
previous work, notably the first published study (2), that used the SAS syntax. The remaining 22 studies did not 
attribute their decision rules to another source (3,6,8,36-54). Most studies (42 of 54) defined nonwear time as 60 
minutes or more of consecutive zeros, with or without allowance for interruptions, variously defined (Table 2). One 
study defined 10 minutes or more of identical consecutive nonzero counts as missing data (38). Seven studies that 
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focused on children or adolescents or both defined nonwear time as 20 minutes or more of consecutive zeros 
(8,39,42,45,47,48). Four studies did not define a valid day; however, 2 of these studies may have implemented decision 
rules embedded in the NCI-supplied SAS syntax, which they reported using. Regardless, 49 of 54 studies defined a 
valid day as 10 hours or more of wear. The minimum number of valid days required for a participant to be included in 
the analysis varied; 17 studies required a minimum of 1 day; 23 studies required a minimum of 4 days; and 10 required 
a minimum of 4 days, including 1 weekend day.
Studies on adults typically presented multiple accelerometer-derived variables (Table 3). Definitions differed for some 
similarly named variables. For example, some studies defined time in sedentary behavior as less than 100 activity 
counts per minute; others defined it as less than 260 activity counts per minute. Time in light intensity was defined as 
100 to 759 activity counts per minute, 100 to 573 activity counts per minute, 100 to 1,951 activity counts per minute, 
100 to 2,019 activity counts per minute, 260 to 1,951 activity counts per minute, and 500 to 2,019 activity counts per 
minute. Time in moderate- to vigorous-intensity physical activity (MVPA) was defined as 500 or more activity counts 
per minute, 574 or more activity counts per minute, 760 or more activity counts per minute, 1,000 or more activity 
counts per minute, 1,500 or more activity counts per minute, 1,952 or more activity counts per minute, 2,000 or more 
activity counts per minute, or 2,020 or more activity counts per minute. Time in MVPA was sometimes considered as 
any minute above the cut point and at other times only as minutes within a bout of 10 minutes or more (which may or 
may not have allowed for an interruption of 1 or 2 minutes below the cut point). Step data were reported in 2 ways: 1) 
in a raw or uncensored format (ie, not adjusted in any way) and 2) following a process of censoring steps from any 
minute with less than 500 activity counts per minute. (The latter process was designed to interpret the higher values of 
accelerometer-based step data against lower pedometer-based scales.) Physical activity levels were categorized 
according to a step-defined graduated index. Additional accelerometer-derived variables included time in incremental 
cadence (steps per minute) bands and peak cadence indicators (defined as the highest level of physical activity, or 
natural best effort, measured during a given day).
The 2 primary cut point definitions of time spent in MVPA for studies on children or adolescents or both were age-
specific values, building on previous research (55), and 3,000 or more activity counts per minute (Table 4). Bouts were 
defined as any minute, 1 to 4 minutes, 5 to 9 minutes, and 10 or more minutes above threshold, again at times allowing 
for minimal interruptions below the cut point. Uncensored and censored steps per day were reported. Data were also 
presented according to a child-specific step-defined graduated index.
Discussion
An obvious advantage of NHANES accelerometer data is that they reflect objectively measured behaviors that can be 
examined, compared, and related to other NHANES data. NCI-supplied SAS syntax has facilitated analysis of these 
data. When studies in our review did not explicitly report some decision rules, they frequently reported use of SAS 
syntax or they cited previous methods that had used this tool, suggesting that SAS syntax was likely applied. Clearly, 
researchers have treated, analyzed, and reported PAM data in nonstandardized ways, which compromises the ability to 
make comparisons among studies. This lack of uniformity is perhaps most apparent in the multiple cut point 
definitions of time spent in MVPA. Inconsistent approaches will impede the ability to track behaviors over time in the 
United States and compare US behaviors with behaviors in other countries.
The intent of this review was neither to judge researchers’ decisions about examining PAM data nor to make 
pronouncements on the most appropriate strategies. Unique research questions may require equally unique analytical 
approaches; some degree of inconsistency must be tolerated if scientific discovery is to be encouraged. That being said, 
consumers (including the research community) of these data must be informed about inconsistencies, especially when 
different cut point definitions are used for similarly named variables.
One of the primary challenges to implementing a measure of accelerometer-based physical activity in a study is 
ensuring compliance with monitoring protocols. The 2003–2004 and 2005–2006 NHANES protocols asked 
participants to remove the accelerometer only during sleep and water-based activities (eg, swimming, showering, 
bathing). Conclusions about accelerometer-based behavior are affected by definitions of nonwear time and a valid day 
(56). Most studies included in our review defined nonwear time as 60 minutes or more of consecutive zeros. 
Differences between allowances for interruptions may simply represent reporting discrepancies, especially because 
many of the studies catalogued in Table 2 also reported using SAS syntax (or cited methods of previous work that did). 
The NCI decision to use 60 minutes of consecutive zeros to identify nonwear time was based on research by Mâsse et al 
(57). These researchers demonstrated that sample sizes were optimized when nonwear time was defined as 60 
minutes, rather than 20 minutes, of continuous zeros. A recent study indicated that 90 minutes of continuous zeros 
may provide more accurate estimates of time in sedentary and active behaviors (58).
Researchers were also almost perfectly consistent in defining a valid day as 10 or more hours of wear time, which is 
also the definition provided by SAS syntax. (In 2 of the 4 studies that did not report nonwear criteria, we assumed that 
they used this definition because they reported using SAS syntax.) Mâsse et al (57) compared results of studies that 
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used different definitions of a valid day, and although they did not recommend a specific number of hours of wear time 
to define a valid day, they noted that the strictest requirement (≥12 h/d) negatively affected sample size. They also 
speculated that stricter requirements might unduly limit inclusion of inactive people, thereby affecting overall data 
distribution. The popularity of using 10 or more hours of wear time to define a valid day is likely due to numerous 
factors: 1) it was a component of one of the decision-rule algorithms evaluated by Mâsse et al (57); 2) it was used in the 
seminal NHANES PAM data publication (2); and 3) it was built into the NCI-provided SAS syntax to accompany the 
NHANES accelerometer data. Using 2005–2006 NHANES data, Tudor-Locke et al (7) showed that, as population 
estimates of nonwear increase, all other time in intensity (eg, MVPA) and volume (ie, activity counts/d, steps/d) 
indicators decrease to some degree, but the negative effect is most pronounced on estimates of time spent in sedentary 
behavior. Nonwear time is more likely to reflect time spent in sedentary behaviors than in active behaviors. Mâsse et al 
(57) reached a similar conclusion: varying minimal wear-time requirements primarily affected minutes of inactivity 
(their preferred term). Others concluded the same (22). The effect of reduced wear time on estimates of sedentary 
behavior should not differ by age. Although there is apparent consensus that 10 or more hours of wear time is adequate 
to define a valid day, a 24-hour wear-time protocol would remove much ambiguity from analysis (59).
Regardless of how scientists have analyzed NHANES accelerometer data, however, it remains clear that the US 
citizenry is not very active. Troiano et al (2) reported that less than 5% of adults achieve public health guidelines, 
although this low estimate may be an artifact of the minimal bout criterion and a cut point definition that was based 
primarily on locomotor activities. Matthews et al (3) reported that more than 50% of monitored time is spent in 
sedentary behaviors. Tudor-Locke et al (12) reported that NHANES adults took an average of approximately 6,500 
steps/day (considered “low active” on a pedometer-based scale). Using identical accelerometer models and analytic 
methods to directly compare Swedish data with NHANES data, Hagströmer et al (43) showed that the amount of time 
spent in MVPA was not uniformly greater in Sweden than in the United States, even though Sweden has a population 
that is generally considered to be quite active.
Although we limited our online search to English-language articles indexed in PubMed, we are confident that this 
search engine was the best one for identifying articles on NHANES accelerometer data. This free resource is 
maintained by the National Center for Biotechnology Information at the US National Library of Medicine, which is 
located at the National Institutes of Health. We included only 1 article that was not indexed in PubMed. Our search 
spanned 2007 (the year that these data were released) through 2011; however, we acknowledge there may be 
additional forthcoming articles that we did not identify. This review necessarily represents a limited time frame.
NHANES accelerometer data represent an important public use resource for researchers and practitioners engaged in 
designing and directing health programs and services and developing public health policy. This review was undertaken 
to summarize existing research that has used these data. The studies we identified bear evidence of the multiple and 
diverse uses of these data, and we can anticipate that they will continue to be used in epidemiologic and health sciences 
research. We hope that the resulting catalog of accelerometer decision rules, derived variables, and cut point 
definitions used to analyze these NHANES data serves as a useful starting point for future researchers to consider as 
they plan and report their own analyses.
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Table 1. Studies Published Since 2007 (or Forthcoming) on Physical Activity 
Monitor Data, National Health and Nutrition Examination Surveys, 2003–
2004 and 2005–2006
Reference Purpose
Years of 
Study Study Sample Size
Age of Study 
Participants, y
Troiano and 
Dodd (1)
Compare self-reported PA to objectively 
measured PA
2003–
2004
3,087 ≥20
Troiano et al 
(2)
Describe objectively measured PA 2003–
2004
4,867 with ≥4 d, 6,329 
with ≥1 d
≥6
Matthews et al 
(3)
Describe objectively measured time in 
sedentary behaviors
2003–
2004
6,329 6–85
Tudor-Locke 
et al (4)
Describe objectively measured step-defined 
PA in children and youth
2005–
2006
2,610 6–19
Tudor-Locke 
et al (5)
Describe peak stepping cadence in adults 2005–
2006
3,522 ≥20
Fan et al (6) Validate self-reported PA for cholesterol 
control
2003–
2004
789 ≥18
Tudor-Locke 
et al (7)
Examine effects of wear time on 
accelerometer-derived variables
2005–
2006
3,744 ≥20
Mark and 
Janssen (8)
Examine dose-response relationship 
between objectively measured PA and 
blood pressure in children and adolescents
2003–
2004
1,170 8–17
Sisson et al 
(9)
Examine associations between steps/d and 
metabolic syndrome and cardiovascular 
risk factors
2005–
2006
1,446 ≥20
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Reference Purpose
Years of 
Study Study Sample Size
Age of Study 
Participants, y
Lynch et al 
(10)
Examine relationship of objectively 
measured PA and sedentary time with 
adiposity in breast cancer survivors
2003–
2004 and 
2005–
2006
111 Mean 69.2
Lynch et al 
(11)
Examine the relationship between 
objectively measured PA, sedentary time, 
and waist circumference of prostate cancer 
survivors
2003–
2004 and 
2005–
2006
103 Mean 75.4
Tudor-Locke 
et al (12)
Describe objectively measured step-defined 
PA
2005–
2006
3,744 20–85
Tudor-Locke 
et al (13)
Compare objectively measured PA and 
inactivity profiles in normal-weight, 
overweight, and obese US men and women
2005–
2006
3,522 ≥20
Clark et al 
(14)
Examine the relationship between self-
reported television viewing time and 
accelerometer-determined total sedentary 
time
2003–
2004, and 
2005–
2006
5,738 ≥20
Healy et al 
(15)
Examine the relationship between 
accelerometer-determined sedentary time 
and cardiometabolic health
2003–
2004 and 
2005–
2006
4,757 ≥20
Tucker et al 
(16)
Assess self-reported and objectively 
measured PA relative to 2008 Physical 
Activity Guidelines for Americans
2005–
2006
3,082 ≥20
Tudor-Locke 
et al (17)
Examine relationship between steps/d and 
other accelerometer-derived variables
2005–
2006
3,744 ≥20
Camhi et al 
(18)
Describe accelerometer-determined 
lifestyle activities and relationship with 
MVPA
2005–
2006
3,744 ≥20
Lynch et al 
(19)
Examine relationship between objectively 
measured PA, sedentary time, and 
biomarkers of breast cancer risk
2003–
2004 and 
2005–
2006
1,024 ≥20
Tudor-Locke 
et al (20)
Describe patterns of stepping cadence in 
adults
2005–
2006
3,744 ≥20
Evenson et al 
(21)
Describe objectively measured PA and 
sedentary behavior in adults 60 years or 
older
2003–
2004 and 
2005–
2006
2,630 ≥60
Winkler et al 
(22)
Compare methods of identifying sedentary 
time using automated estimates of 
accelerometer wear time
2003–
2004
4,741 ≥20
Vallance et al 
(23)
Examine the relationship between 
objectively measured PA, sedentary time, 
and depression
2005–
2006
2,862 ≥20
Peart et al 
(24)
Assess association between objectively 
measured PA, diet, sedentary behaviors, 
and overweight and obesity in US youth
2003–
2004 and 
2005–
2006
2,638 12–19
Lee et al (25) Examine the relationship between 
socioeconomic status and acculturation on 
objectively measured MVPA among Mexican 
American adolescents
2003–
2004
322 13–19
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Reference Purpose
Years of 
Study Study Sample Size
Age of Study 
Participants, y
Gortmaker et 
al (26)
Examine changes in child/adolescent PA by 
race/ethnicity between NHANES cycles
2003–
2004 and 
2005–
2006
3,381 6–19
Smith et al 
(27)
Compare objectively measured PA levels 
among 5-year cancer survivors with those 
with no history of cancer
2003–
2004 and 
2005–
2006
Not reported ≥20
Yang et al 
(28)
Examine relationship between receiving 
health care provider’s recommendation and 
adherence to healthy lifestyle among adults 
with prediabetes
2005–
2006
2,853 ≥20
Bankoski et al 
(29)
Examine the relationship between 
accelerometer-determined sedentary time 
and metabolic syndrome independent of PA
2003–
2004 and 
2005–
2006
1,367 ≥60
Belcher et al 
(30)
Describe objectively measured PA by 
race/ethnicity, age, sex, and weight status 
in youth
2003–
2004 and 
2005–
2006
3,106 6–19
Mendoza et al 
(31)
Examine the relationship between active 
commuting to school and objectively 
measured PA and adiposity
2003–
2004
789 12–19
Luke et al 
(32)
Examine the relationship of objectively 
measured PA with cardiovascular risk 
factors
2003–
2004, and 
2005–
2006
3,370 20–65
Van Domelen 
et al (33)
Examine the relationship between 
employment and objectively measured PA
2003–
2004
1,826 20–60
Holman et al 
(34)
Determine whether sporadic vs bout 
accumulation of MVPA was more strongly 
associated with cardiometabolic risk in 
children and youth
2003–
2004 and 
2005–
2006
2,754 6–19
Loprinzi et al 
(35)
Examine association between objectively 
measured PA and C-reactive protein
2003–
2004
4,555 ≥6
Strath et al 
(36)
Describe objectively measured MVPA 
accumulation in bouts/nonbouts in relation 
to obesity
2003–
2004
3,272 Waist 
circumference analysis; 
3,250 body mass index 
analysis
≥18
Janney et al 
(37)
Examine relationship between objectively 
measured PA levels and use of mental 
health services
2003–
2004
3,809 18–85
Metzger et al 
(38)
Describe patterns of objectively measured 
PA
2003–
2004
3,802 ≥1 d, 3,462 ≥3 d 20–85
Mark and 
Janssen (39)
Compare MVPA bouts vs nonbouts in 
predicting overweight in youth
2003–
2004 and 
2005–
2006
2,498 8–17
Hawkins et al 
(40)
Examine objectively measured PA among 
sex, age, and racial/ethnic groups
2003–
2004
2,688 ≥18
Metzger et al 
(41)
Examine patterns of objectively measured 
PA associated with metabolic syndrome
2003–
2004
1,620 20–85
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Reference Purpose
Years of 
Study Study Sample Size
Age of Study 
Participants, y
LeBlanc and 
Janssen (42)
Determine dose-response relationship 
between objectively measured PA and 
dyslipdemia in youth
2003–
2004, and 
2005–
2006
1,235 12–19
Hagströmer et 
al (43)
Compare objectively measured PA between 
Sweden and United States
2003–
2004
2,925 18–75
Ham and 
Ainsworth 
(44)
Describe disparities in objectively 
measured PA
2003–
2004
3,043 ≥18
LeBlanc and 
Janssen (45)
Examine differences between objective and 
self-reported MVPA in youth
2003–
2004 and 
2005–
2006
2,761 12–19
Atienza et al 
(46)
Examine the independent associations of 
self-reported and objectively measured 
MVPA with physiologic and anthropometric 
biomarkers
2003–
2004 and 
2005–
2006
5,797 ≥20
Carson and 
Janssen (47)
Examine the relationship between 
sedentary behavior and cardiometabolic 
health in children and adolescents
2003–
2004 and 
2005–
2006
2,527 6–19
Mark et al 
(48)
Explore effects of objectively measured PA 
intensity and incidental movement on body 
fat in children and youth
2003–
2004
1,165 8–17
Hawkins et al 
(49)
Examine the relationship between 
objectively measured PA intensity and 
kidney function
2003–
2004 and 
2005–
2006
2,117 ≥18
Camhi et al 
(50)
Examine the relationship between 
accelerometer-determined lifestyle 
activities and cardiometabolic health
2005–
2006
1,371 ≥18
Tudor-Locke 
et al (51)
Compute a steps/d translation of time in 
MVPA
2005–
2006
1,197 ≥20
Evenson et al 
(52)
Describe objectively measured PA and 
sedentary behavior in pregnant women
2003–
2004 and 
2005–
2006
359 ≥16
Chasens and 
Yang (53)
Examine the relationship between insomnia 
and objectively measured PA in adults with 
prediabetes
2005–
2006
958 ≥20
Mendoza et al 
(54)
Examine the relationship of objectively 
measured MVPA and pediatric metabolic 
risk
2003–
2004, 
2005–
2006
2,155 6–19
Abbreviations: PA, physical activity; MVPA, moderate- to vigorous-intensity PA; NHANES, National Health and Nutrition 
Examination Survey.
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Table 2. Rules for Data in Studies Published Since 2007 (or Forthcoming) on 
Accelerometer Data, National Health and Nutrition Examination Surveys, 2003–
2004 and 2005–2006
Rule
No. of 
Studies References
Nonwear (time that the accelerometer was not likely worn) or missing
≥60 min of consecutive zeros 11 (5,20,22,24,27,36-38,40,41,49)
≥60 min of consecutive zeros with allowance for up to 2 
min up to 100 activity counts/min
25 (1-4,6,7,9,12,13,15-18,21,22,26,29-
33,43,44,46,52)
≥60 consecutive zeros with allowance for up to 2 min 
<50 activity counts/min
5 (10,11,14,19,22)
≥60 consecutive zeros with allowance for interruptions 1 (23)
≥10 min identical consecutive nonzero counts 1 (38)
≥20 min of consecutive zeros 7 (8,34,39,42,45,47,48)
Not reported 7 (25,28,35,50,51,53,54)
Valid day (minimum no. of wear-hours required to be considered representative of a day’s behavior)
10 h 49 (1-20,22-26,28-37,39,40,42-51,53,54)
Length of time that 70% of sample wore the 
accelerometer, multiplied by 70%
1 (52)
Not reported 4 (21,27,38,41)
Minimum no. of valid days required for a participant to be included in the analysis
All (missing data imputed) 1 (41)
1 17 (2-7,9,12,13,17,18,20,22,38,50,51,54)
2 1 (53)
3 1 (21,38)
4 23 (1,2,14,16,22-26,29-33,35-
37,40,43,46,49,52,54)
4, including 1 weekend day 10 (8,15,19,34,39,42,44,45,47,48)
Not reported 5 (10,11,27,28)
 Decision rules embedded in the National Cancer Institute–supplied SAS syntax may have been used.
 
Table 3. Accelerometer-Derived Variables and Cut Point Definitions Used in 
Studies Published Since 2007 (or Forthcoming) on Accelerometer Data for 
Adults, National Health and Nutrition Examination Surveys, 2003–2004 and 2005
–2006
Accelerometer-derived 
variable Cut point definition Reference
Activity counts/d Sum of daily activity counts (13)
Mean activity counts/min Sum of daily activity counts/number of min 
worn
(2,6,13,21,30,32,33,35,43,52)
Mean counts/min of most 
intense 10 min/wk
≥2,020 Activity counts/min (6)
a
a
a
a
a
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Accelerometer-derived 
variable Cut point definition Reference
Time in sedentary behaviors 
(any min)
<100 Activity counts/min (3,7,10,11,13-15,17,19,21-
23,29,30,33,43,49,52)
Steps in sedentary 
behaviors (any min)
Steps detected <100 activity counts/min (12)
Time in sedentary behaviors 
(>5-min bouts)
<100 Activity counts/min (29)
Time in sedentary behaviors 
(any min)
<260 Activity counts/min (37,40)
Proportion of sedentary time Proportion of valid wear time at <100 activity 
counts/min
(29,33)
Stillness Average intensity during time <100 activity 
counts/min
(29)
Time in inactive intensity 
(any min)
100–499 Activity counts/min (12)
Steps in inactive intensity 
(any min)
Steps detected 100–499 activity counts/min (12)
Time in low intensity (any 
min)
100–499 Activity counts/min (7,13,17)
Time in low intensity (any 
min)
100–759 Activity counts/min (43)
Time in lifestyle intensity 
(any min)
760–2,019 Activity counts/min (18,33,43,50)
Proportion of time in 
lifestyle intensity
Proportion of valid wear time at 760–2,019 
activity counts/min
(18,33)
Steps in lifestyle intensity 
(any min)
Steps detected 760–2,019 activity counts/min (18,50)
Proportion of steps/d in 
lifestyle activity
Proportion of steps/d at 760–2,019 activity 
counts/min
(18)
Time in light intensity (any 
min)
100–573 Activity counts/min (52)
Time in light intensity (any 
min)
100–759 Activity counts/min (33)
Time in light intensity (any 
min)
100–1,951 Activity counts/min (10,11,15,23,49)
Time in light intensity (any 
min)
260–1,951 Activity counts/min (37,40)
Time in light intensity (any 
min)
100–2,019 activity counts/min (52)
Time in light intensity (any 
min)
500–2,019 Activity counts/min (12,13,17)
Proportion of time in light 
intensity
Proportion of valid wear time at 100–759 
activity counts/min
(33)
Steps in light intensity (any 
min)
Steps detected in 500–2,019 activity 
counts/min
(12)
Time in moderate-intensity 
activity (any min)
574–4,944 Activity counts/min (52)
Time in moderate-intensity 
activity (any min)
2,020–5,998 Activity counts/min (2,6,16,17,27,30,35,38,52)
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Accelerometer-derived 
variable Cut point definition Reference
Steps in moderate-intensity 
activity (any min)
Steps detected in 2,020–5,998 activity 
counts/min
(12)
Time in moderate intensity 
(modified 10-min bouts)
≥500 Activity counts/min (21)
Time in moderate intensity 
(modified 10-min bouts)
760–5,999 Activity counts/min (44)
Time in moderate intensity 
(modified 10-min bouts)
≥1,000 Activity counts/min (21)
Time in moderate intensity 
(modified 10-min bouts)
≥1,500 Activity counts/min (21)
Time in moderate intensity 
(modified 10-min bouts)
≥2,000 Activity counts/min (21)
Time in moderate intensity 
(≥10-min bouts)
≥2020 Activity counts/min (53)
Time in moderate intensity 
(modified 10-min bouts)
2,020–5,998 Activity counts/min (2,13,28)
Time in vigorous-intensity 
activity (any min)
≥4,945 Activity counts/min (52)
Time in vigorous-intensity 
activity (any min)
≥5,999 Activity counts/min (2,7,12,13,16,17,27,30,32,35,38,52)
Time in vigorous (any min) Not reported (6)
Steps in vigorous-intensity 
activity (any min)
Steps detected ≥5,999 activity counts/min (12)
Time in vigorous intensity 
(modified 10-min bouts)
≥5,999 Activity counts/min (2,28,32,44)
Time in MVPA (any min) ≥500 Activity counts/min (21)
Time in MVPA (any min) ≥574 Activity counts/min (52)
Time in MVPA (any min) ≥760 Activity counts/min (37)
Time in MVPA (any min) ≥1,000 Activity counts/min (21)
Time in MVPA (any min) ≥1,500 Activity counts/min (21)
Time in MVPA (any min) ≥1,952 Activity counts/min (10,11,19,22,23,37,40)
Time in MVPA (any min) ≥2,000 Activity counts/min (21)
Time in MVPA (any min) ≥2,020 Activity counts/min (2,7,18,33,41,43,50-52)
Proportion of time in MVPA Proportion of valid wear time ≥2,020 activity 
counts/min
(18,33)
Time in MVPA (any min 
outside a ≥10-min bout)
≥760 Activity counts/min (36)
Time in MVPA (modified 10-
min bouts)
≥2,020 Activity counts/min (1,6,18,28,38,46)
Time in MVPA (in bouts ≥10 
min)
≥760 Activity counts/min (36)
Time in MVPA (in bouts ≥10 
min)
≥2,020 Activity counts/min (35)
Time active >100 Activity counts/min (29)
Time in total PA ≥260 Activity counts/min (40)
Day/wk ≥MVPA ≥2,020 Activity counts/min (6)
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Accelerometer-derived 
variable Cut point definition Reference
Adherence to PA 
recommendations (modified 
10-min bout)
30 Min of moderate or greater intensity 
activity on 5 of 7 d
(2,13)
Uncensored (raw) steps/d Reporting steps as detected (9,12,13,20,28,51,53)
Censored steps/d Disqualify steps taken at less than 500 
activity counts/min
(9,12,13)
Uncensored (raw) steps/min Total raw steps accumulated during 1,440 
min (24 h or 1 d), divided by time worn
(13)
Censored steps/min Total steps accumulated during 1,440 min 
after censoring out steps at an intensity <500 
activity counts/min, divided by time worn
(13)
Transitions/d Total occurrences of when activity counts rose 
from <100 activity/counts in 1 min to ≥100 
activity counts in the subsequent min
(13,15,29)
Basal physical activity <2,500 Steps/d (5,12,13)
Limited physical activity 2,500–4,999 Steps/d (5,12,13)
Sedentary <5,000 Steps/d (9,28)
Low active 5,000–7,499 Steps/d (5,12,13,28)
Low- to somewhat active 5,000–9,999 Steps/d (9)
Somewhat active 7,500–9,999 Steps/d (5,12,13,28)
Active to highly active ≥10,000 Steps/d (9)
Active 10,000–12,499 Steps/d (5,12,13)
Active ≥10,000 Steps/d (28)
Highly active ≥12,500 Steps/d (5,12,13)
Time in incremental cadence 
bands
0 Steps/min (nonmovement)
(20)
1–19 Steps/min (incidental movement)
20–39 Steps/min (sporadic movement)
40–59 Steps/min (purposeful steps)
60–79 Steps/min (slow walking)
80–99 Steps/min (medium walking)
100–119 Steps/min (brisk walking)
≥120 Steps/min (all faster human locomotor 
movements)
Peak 1-min cadence Steps/min recorded for the single highest min 
in a day
(5)
Peak 30-min cadence Average steps/min recorded for the 30 
highest, but not necessarily consecutive, min 
in a day
(5)
Abbreviation: MVPA, moderate- to vigorous-intensity physical activity. 
 Hagströmer et al (43) also reported the number of bouts and accumulated time in each bout in each intensity category 
(sedentary, low, lifestyle, and moderate or greater). A sedentary bout was defined as more than 5 consecutive minutes 
within the designated count range, including an allowance for 1 minute above threshold (29). An MVPA bout was defined as 
10 or more consecutive minutes within the designated count range, including an allowance for interruption of 1 or 2 minutes 
below threshold. Metzger et al (38) considered 70% of minutes above threshold in a 10-minute bout; all others considered 
80%.
 
a
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Table 4. Derived Variables and Cut Point Definitions Used in Studies 
Published Since 2007 (or Forthcoming) on Accelerometer Data for Children 
and/or Adolescents, National Health and Nutrition Examination Surveys, 2003–
2004 and 2005–2006
Accelerometer-derived variable Cut point definition Reference
Mean activity counts/min Sum of daily activity counts/number of min 
worn
(2,26,35)
Time in sedentary behaviors <100 Activity counts/min (3,30,47)
Sedentary behavior bout ≥30 Min with ≥80% of min <100 activity 
counts/min (no more than 5 consecutive 
min ≥100 activity counts/min
(47)
Break min Within each sedentary behavior bout 
(defined above), those mins ≥100 activity 
counts/min
(47)
Time in incidental movement (any 
movement)
<2,000 Activity counts/min (48)
Time in low intensity (any movement) 2,000–2,999 Activity counts/min (48)
Time in low intensity Between 100 activity counts/min and age-
specific cut point definitions (55)
(47)
Time in moderate-intensity activity (any 
min)
Age-specific cut point definitions (55) (2,30,38)
Time in moderate-intensity activity (any 
min)
3000–5,199 Activity counts/min (48)
Time in moderate- intensity activity 
(modified 10-min bouts)
Age-specific cut point definitions (55) (2)
Time in vigorous-intensity activity (any 
min)
Age-specific cut point definitions (55) (2,30)
Time in vigorous-intensity activity (any 
min)
≥5200 Activity counts/min (48)
Time in vigorous-intensity activity 
(modified 10-min bouts)
Age-specific cut point definitions (55) (2)
Time in MVPA (any min) Age-specific cut point definitions (55) (2,25,26,30,31,34,35,47,54)
Time in sporadic MVPA (any min <5 min) Age-specific cut point definitions (55) (34)
Time in sporadic MVPA (any min <10 min) Age-specific cut point definitions (55) (34)
Time in MVPA (any min) ≥1,500 Activity counts/min (24)
Time in MVPA (any min) ≥3,000 Activity counts/min (8,39,42)
Time in MVPA (1- to 4-min bouts) ≥3000 Activity counts/min (39,42,45)
Time in MVPA (modified 5- to 9-min bouts) ≥3000 Activity counts/min (39,42,45)
Time in MVPA (modified 10-min bouts) ≥3,000 Activity counts/min (39,42)
Time in MVPA (≥5-min bouts) Age-specific cut point definitions (55) (34)
Time in MVPA (≥10-min bouts) Age-specific cut point definitions (55) (34)
Time in moderate-intensity activity 
(modified 10-min bouts)
Age-specific cut point definitions (55) (2)
Time in total PA ≥2,000 activity counts/min (8)
Adherence to PA recommendations 
(children, any min; adolescents, any min 
and modified 10-min bout)
30 min of moderate- or greater-intensity 
activity on 5 of 7 d
(2)
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Accelerometer-derived variable Cut point definition Reference
Uncensored (raw) steps/d Reporting steps as detected (4)
Censored steps/d Disqualify steps taken <500 activity 
counts/min
(4)
Sedentary <10,000 Steps/d (boys aged 6–11); 
<7,000 steps/d (girls aged 6–11)
(4)
Low active 10,000–12,499 Steps/d (boys aged 6–11); 
7,000–9,499 steps/d (girls aged 6–11)
(4)
Somewhat active 12,500–14,999 Steps/d (boys aged 6–11); 
9,500–11,999 steps/d (girls aged 6–11)
(4)
Active 15,000–17,499 Steps/d (boys aged 6–11); 
12,000–14,499 steps/d (girls aged 6–11)
(4)
Highly active ≥17,500 Steps/d (boys aged 6–11); 
≥14,500 steps/d (girls aged 6–11)
(4)
Abbreviations: PA, physical activity; MVPA, moderate- to vigorous-intensity PA.
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